KRMD logo

KORU Medical Systems, Inc. Stock Price

NasdaqCM:KRMD Community·US$188.6m Market Cap
  • 0 Narratives written by author
  • 0 Comments on narratives written by author
  • 6 Fair Values set on narratives written by author

KRMD Share Price Performance

US$4.02
1.47 (57.65%)
US$4.02
1.47 (57.65%)
Price US$4.02

KRMD Community Narratives

There are no narratives available yet.

Snowflake Analysis

Excellent balance sheet and slightly overvalued.

1 Risk
2 Rewards

KORU Medical Systems, Inc. Key Details

US$36.8m

Revenue

US$13.6m

Cost of Revenue

US$23.3m

Gross Profit

US$27.8m

Other Expenses

-US$4.5m

Earnings

Last Reported Earnings
Jun 30, 2025
Next Reporting Earnings
n/a
-0.098
63.15%
-12.25%
0%
View Full Analysis

About KRMD

Founded
1980
Employees
80
CEO
Linda Tharby
WebsiteView website
www.korumedical.com

KORU Medical Systems, Inc. develops, manufactures, and commercializes subcutaneous infusion solutions primarily for the subcutaneous drug delivery market in the United States and internationally. The company offers the freedom infusion systems to deliver life-saving therapies to patients with chronic illnesses, such as primary immunodeficiency diseases (PIDD), chronic inflammatory demyelinating polyneuropathy (CIDP), secondary immunodeficiency disorder (SIDD), and paroxysmal nocturnal hemoglobinuria (PNH). Its products include the FREEDOM60 and FreedomEdge syringe driver, HIgH-Flo subcutaneous safety needle sets, and precision flow rate tubing products. The company was formerly known as Repro Med Systems, Inc. and changed its name to KORU Medical Systems, Inc. in March 2022. KORU Medical Systems, Inc. was incorporated in 1980 and is headquartered in Mahwah, New Jersey.

Recent KRMD News & Updates

Recent updates

No updates